Literature DB >> 12185272

Replication of a hepatitis A virus replicon detected by genetic recombination in vivo.

Verena Gauss-Müller1, Yuri Y Kusov1.   

Abstract

Unlike other picornaviruses, hepatitis A virus (HAV) replicates so inefficiently in cell culture that the study of its RNA biosynthesis presents a major experimental challenge. To assess viral RNA replication independent of particle formation, a subgenomic replicon representing a self-replicating RNA was constructed by replacing the P1 domain encoding the capsid proteins with the firefly luciferase sequence. Although translation of the HAV replicon was as efficient as a similar poliovirus replicon, the luciferase activity derived from replication of the HAV construct was more than 100-fold lower than that of poliovirus. The replication capacity of the HAV replicon was clearly demonstrated by its ability to recombine genetically with a non-viable, full-length HAV genome that served as capsid donor and thus to rescue a fully infectious virus. In contrast to a replication-deficient replicon, co-expression of the genetically marked and replication-competent HAV replicon with several lethally mutated HAV genomes resulted in the successful rescue of infectious HAV with a unique genetic marker. Our data suggest: (i) that autonomous HAV RNA replication does not require sequences for the HAV structural proteins; and (ii) that low-level genome replication can unequivocally be demonstrated by the rescue of infectious virus after co-expression with non-viable genomes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12185272     DOI: 10.1099/0022-1317-83-9-2183

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  17 in total

1.  Silencing of hepatitis A virus infection by small interfering RNAs.

Authors:  Yuri Kusov; Tatsuo Kanda; Ann Palmenberg; Jean-Yves Sgro; Verena Gauss-Müller
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

2.  Biochemical and structural characterization of hepatitis A virus 2C reveals an unusual ribonuclease activity on single-stranded RNA.

Authors:  Pu Chen; Justyna Aleksandra Wojdyla; Ombretta Colasanti; Zhijian Li; Bo Qin; Meitian Wang; Volker Lohmann; Sheng Cui
Journal:  Nucleic Acids Res       Date:  2022-08-10       Impact factor: 19.160

3.  Amantadine and Rimantadine Inhibit Hepatitis A Virus Replication through the Induction of Autophagy.

Authors:  Reina Sasaki-Tanaka; Toshikatsu Shibata; Mitsuhiko Moriyama; Hiroaki Okamoto; Hirofumi Kogure; Tatsuo Kanda
Journal:  J Virol       Date:  2022-08-30       Impact factor: 6.549

4.  3C protease of enterovirus 68: structure-based design of Michael acceptor inhibitors and their broad-spectrum antiviral effects against picornaviruses.

Authors:  Jinzhi Tan; Shyla George; Yuri Kusov; Markus Perbandt; Stefan Anemüller; Jeroen R Mesters; Helene Norder; Bruno Coutard; Céline Lacroix; Pieter Leyssen; Johan Neyts; Rolf Hilgenfeld
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

5.  Inhibitory effects on HAV IRES-mediated translation and replication by a combination of amantadine and interferon-alpha.

Authors:  Lingli Yang; Tomoko Kiyohara; Tatsuo Kanda; Fumio Imazeki; Keiichi Fujiwara; Verena Gauss-Müller; Koji Ishii; Takaji Wakita; Osamu Yokosuka
Journal:  Virol J       Date:  2010-09-03       Impact factor: 4.099

6.  DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture.

Authors:  Oliver Grünvogel; Katharina Esser-Nobis; Anna Reustle; Philipp Schult; Birthe Müller; Philippe Metz; Martin Trippler; Marc P Windisch; Michael Frese; Marco Binder; Oliver Fackler; Ralf Bartenschlager; Alessia Ruggieri; Volker Lohmann
Journal:  J Virol       Date:  2015-08-12       Impact factor: 5.103

7.  Functional binding of hexanucleotides to 3C protease of hepatitis A virus.

Authors:  Bärbel S Blaum; Winfried Wünsche; Andrew J Benie; Yuri Kusov; Hannelore Peters; Verena Gauss-Müller; Thomas Peters; Georg Sczakiel
Journal:  Nucleic Acids Res       Date:  2011-12-10       Impact factor: 16.971

8.  Translation directed by hepatitis A virus IRES in the absence of active eIF4F complex and eIF2.

Authors:  Natalia Redondo; Miguel Angel Sanz; Jutta Steinberger; Tim Skern; Yuri Kusov; Luis Carrasco
Journal:  PLoS One       Date:  2012-12-18       Impact factor: 3.240

9.  Poly(A) binding protein, C-terminally truncated by the hepatitis A virus proteinase 3C, inhibits viral translation.

Authors:  Bo Zhang; Graziella Morace; Verena Gauss-Müller; Yuri Kusov
Journal:  Nucleic Acids Res       Date:  2007-08-28       Impact factor: 16.971

10.  Suppression of La antigen exerts potential antiviral effects against hepatitis A virus.

Authors:  Xia Jiang; Tatsuo Kanda; Shuang Wu; Shingo Nakamoto; Kengo Saito; Hiroshi Shirasawa; Tomoko Kiyohara; Koji Ishii; Takaji Wakita; Hiroaki Okamoto; Osamu Yokosuka
Journal:  PLoS One       Date:  2014-07-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.